INVITRO AND INVIVO COMPARATIVE-STUDIES ON IMMUNOSUPPRESSIVE PROPERTIES OF CYCLOSPORINE-A, CYCLOSPORINE-C, CYCLOSPORINE-D AND METABOLITE-M1,METABOLITE-M17, AND METABOLITE-M21
N. Sadeg et al., INVITRO AND INVIVO COMPARATIVE-STUDIES ON IMMUNOSUPPRESSIVE PROPERTIES OF CYCLOSPORINE-A, CYCLOSPORINE-C, CYCLOSPORINE-D AND METABOLITE-M1,METABOLITE-M17, AND METABOLITE-M21, Immunopharmacology and immunotoxicology, 15(2-3), 1993, pp. 163-177
Cyclosporine A (CsA) and its major metabolites : M1, M17 and M21 and t
wo analogues : cyclosporines C (CsC) and D (CsD), were studied for the
ir capacity to interfer with different in vitro activation pathways. T
heir inhibition potentials against the reaction of Graft-versus-Host (
GvH) were also studied. The results showed : CsA, CsC and metabolite M
17 were the most active compounds upon the inhibition of lymphocyte pr
oliferation induced by different mitogens (ConA, PHA, PWM) and also on
the proliferation of mixed lymphocyte cultures (MLC). The same result
s were observed concerning the direct activation by protein kinase C u
sing a combined action of phorbol ester + calcium ionophore. In vivo u
sing local GvH reaction, CsA and CsC proved more active than M17 in th
e two different combinations : H-2d --> (H-2b x H-2d)F1 and H-2k --> (
H-2b x H-2k)F1 CsD and two metabolites M1 and M21 showed no or weak im
munosuppressive effects. Overall, the immunosuppressive potency of six
compounds could be schematized as : CsA greater-than-or-equal-to CsC
> M17 > M1 greater-than-or-equal-to CsD > M21